The microRNA Blood Test That Might Outsmart Alzheimer’s
Recent research highlights the potential of microRNAs as cost-effective and less invasive biomarkers for early diagnosis and prognosis of Alzheimer’s disease. Studies by teams from Boston University and other institutions…